Oxford Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Oxford Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-123,272	Closed	-$593K	–	1630
2019 Q4	$593K	Sell	123,272 -59,115	-32%	-$326K	0.02%	1148
2019 Q3	$1.1M	Sell	182,387 -65,712	-26%	-$410K	0.03%	889
2019 Q2	$1.61M	Sell	248,099 -87,007	-26%	-$613K	0.03%	741
2019 Q1	$2.38M	Buy	335,106 +252,180	+304%	+$1.66M	0.05%	497
2018 Q4	$403K	Buy	+82,926	New	+$432K	0.01%	1282
2016 Q4	–	Sell	-119,066	Closed	-$1.41M	–	912
2016 Q3	$1.41M	Buy	+119,066	New	+$1.15M	0.04%	459
2013 Q3	–	Sell	-107,453	Closed	-$1.11M	–	950
2013 Q2	$1.11M	Buy	+107,453	New	+$1.48M	0.03%	577

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Oxford Asset Management's GNMK Position: Q1 2020 in Review

Oxford Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2020, closing a stake of 123,272 shares — an estimated $593K sold.

Oxford Asset Management first reported a position in GNMK in Q2 2013 and held it in 7 quarters. The position peaked at $2.38M in Q1 2019. 110 funds tracked by Wall St. Rank hold GNMK as of Q1 2020.

Oxford Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 123,272 GenMark Diagnostics, Inc shares in Q1 2020, an estimated $593K.
Oxford Asset Management first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 7 quarters.
Oxford Asset Management's GenMark Diagnostics, Inc position peaked at $2.38M in Q1 2019.
110 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.